Dexferrum and Gabapentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dexferrum (iron dextran) and Gabapentin (gabapentin). Common drug interactions include choking among females and nephrolithiasis among males.

The phase IV clinical study analyzes what interactions people have when they take Dexferrum and Gabapentin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Dexferrum?

Dexferrum has active ingredients of iron dextran. It is often used in anemia. eHealthMe is studying from 716 Dexferrum users. Check the latest studies of Dexferrum.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

On Jul, 30, 2026

11 people who take Dexferrum and Gabapentin together, and have interactions are studied.

Dexferrum and Gabapentin drug interactions.

What are the common drug interactions of Dexferrum and Gabapentin, by gender? *:

female:

Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Oesophagitis (inflammation of oesophagus)
Urinary tract infection

male:

Nephrolithiasis (calculi in the kidneys)
Cheyne-stokes respiration (abnormal pattern of breathing combination of slow and faster)
Coma (state of unconsciousness lasting more than six hours)
Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Renal hypertrophy (over growth of kidney)
Acidosis (build-up of carbon dioxide in the blood)
Coma acidotic (increased acidity in the blood and other body tissue leads to coma)
Depressed level of consciousness
Hypovolaemia (a decreased volume of circulating blood in the body)

What are the common drug interactions of Dexferrum and Gabapentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Cardiomegaly (increased size of heart than normal)
Hyperkalaemia (damage to or disease of the kidney)
Kidney enlargement
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pulmonary oedema (fluid accumulation in the lungs)
Renal failure (kidney dysfunction)
Renal hypertrophy (over growth of kidney)
Stupor (lack of critical cognitive function and level of consciousness)
Acidosis (build-up of carbon dioxide in the blood)

60+:

Anaphylactic reaction (serious allergic reaction)
Hypersensitivity
Respiratory arrest (excl neonatal) (cessation of normal respiration due to failure of the lungs to function effectively (excluding neonatal))

What are the existing conditions these people have? *

Hiv Infection: 5 people, 45.45%
Immunodeficiency Common Variable: 2 people, 18.18%
Gout (uric acid crystals building up in the body): 2 people, 18.18%
Iron Deficiency Anaemia: 1 person, 9.09%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Dexferrum and Gabapentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously